Literature DB >> 18705641

Comparative evaluation of genetic assays to identify oral pre-cancerous fields.

Jantine F Bremmer1, Boudewijn J M Braakhuis, Arjen Brink, Mark A M Broeckaert, Jeroen A M Beliën, Gerrit A Meijer, Dirk J Kuik, C René Leemans, Elisabeth Bloemena, Isaäc van der Waal, Ruud H Brakenhoff.   

Abstract

BACKGROUND: Oral squamous cell carcinomas often develop in a pre-cancerous field, defined as mucosal epithelium with cancer-related genetic alterations, and which may appear as a clinically visible lesion. The test characteristics of three genetic assays that were developed to detect pre-cancerous fields were investigated and compared to histology.
METHODS: In total, 10 pre-cancerous fields that were not visible at clinical inspection and gave rise to malignant transformation based on an identical TP53 mutation in tumor and mucosal epithelium in the surgical margin, as well as 10 normal oral mucosa specimens were analyzed for numerical chromosomal changes with multiplex ligation-dependent probe amplification (MLPA), for loss of heterozygosity (LOH), with microsatellite PCR and for DNA index alterations with DNA image analysis.
RESULTS: No alterations were detected in normal tissue by either of the assays. Both MLPA and LOH assays detected all pre-cancerous fields. DNA cytometry identified aneuploidy in four of 10 pre-cancerous fields, while the corresponding tumors that developed in these fields were shown to be aneuploid.
CONCLUSIONS: Both the MLPA and LOH assay seem suitable for screening pre-cancerous fields in subjects at high risk for oral cancer even in the absence of clinically abnormal appearing oral mucosa. Measurements of DNA index might be valuable to determine the time to progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705641     DOI: 10.1111/j.1600-0714.2008.00682.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Authors:  Aditi Bhattacharya; Ritu Roy; Antoine M Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C K Jordan; Adam B Olshen; Daniel Pinkel; Brian L Schmidt; Donna G Albertson
Journal:  Clin Cancer Res       Date:  2011-11-08       Impact factor: 12.531

Review 2.  Contemporary management of cancer of the oral cavity.

Authors:  Eric M Genden; Alfio Ferlito; Carl E Silver; Robert P Takes; Carlos Suárez; Randall P Owen; Missak Haigentz; Sandro J Stoeckli; Ashok R Shaha; Alexander D Rapidis; Juan Pablo Rodrigo; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

3.  Role of brush biopsy and DNA cytometry for prevention, diagnosis, therapy, and followup care of oral cancer.

Authors:  Alfred Böcking; Christoph Sproll; Nikolas Stöcklein; Christian Naujoks; Rita Depprich; Norbert R Kübler; Jörg Handschel
Journal:  J Oncol       Date:  2010-12-20       Impact factor: 4.375

4.  Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

Authors:  W Giaretti; M Maffei; M Pentenero; P Scaruffi; A Donadini; E Di Nallo; D Malacarne; R Marino; U Familiari; S Coco; G P Tonini; P Castagnola; S Gandolfo
Journal:  Cell Oncol (Dordr)       Date:  2011-12-06       Impact factor: 6.730

Review 5.  Molecular markers in oral lichen planus: A systematic review.

Authors:  Shitalkumar Sagari; Sudhanshu Sanadhya; Mallikarjun Doddamani; Rajan Rajput
Journal:  J Oral Maxillofac Pathol       Date:  2016 Jan-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.